On February 1, 2016, a motion for the appointment of a chapter 11 trustee or an examiner was filed in the bankruptcy case of KaloBios Pharmaceuticals, Inc. and its affiliates.
The filing was assigned docket number 106 and is described on the court’s official docket as follows:
Emergency Motion for Appointment of Chapter 11 Trustee or, in the Alternative, Conversion to a Chapter 7 Case Filed by United States Trustee. (Attachments: # (1) Declaration Declaration of Diane Giordano and Exhibits 1-10 Thereto # (2) Proposed Form of Order) (McCollum, Hannah)
KaloBios Pharmaceuticals, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 29, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-12628. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Morris, Nichols, Arsht & Tunnell LLP is acting as lead bankruptcy counsel to KaloBios Pharmaceuticals, Inc. in the bankruptcy case.